Inactive Instrument

UDG Healthcare plc

Equities

UDG

IE0033024807

UDG Healthcare plc Provides Earnings Guidance for the Full Year Ended September 30, 2019

January 29, 2019 at 04:00 am EST

UDG Healthcare plc provided earnings guidance for the full year of 2019. The company expects constant currency adjusted diluted earnings per share for the year to 30 September 2019 to be between 4% to 6% ahead of last year's EPS of $0.459 cents.

Latest news about UDG Healthcare plc

UDG Healthcare : Clayton, Dubilier & Rice Unit Completes $4 Billion UDG Healthcare Deal	21-08-16	MT
Clayton, Dubilier & Rice Fund X, L.P. and Clayton, Dubilier & Rice Fund XI, L.P. managed by Clayton, Dubilier & Rice, LLC completed the acquisition of UDG Healthcare plc from Kabouter Management L.L.C., Allianz Global Investments, M&G Investment Management Limited and other shareholders.	21-08-15	CI
UDG Healthcare : Takeover by Clayton, Dubilier & Rice to Close on Aug. 16	21-08-12	MT
UDG Healthcare : UK Court Clears CD&R's $4.1 Billion UDG Healthcare Acquisition	21-08-09	MT
UDG Healthcare : Takeover by Clayton, Dubilier & Rice to Complete Later Than Scheduled	21-08-06	MT
UDG Healthcare plc(LSE:UDG) dropped from FTSE 250 Index	21-08-06	CI
UDG Healthcare plc(LSE:UDG) dropped from FTSE 250 (Ex Investment Companies) Index	21-08-06	CI
UDG Healthcare plc(LSE:UDG) dropped from FTSE 350 (Ex Investment Companies) Index	21-08-06	CI
UDG Healthcare plc(LSE:UDG) dropped from FTSE All-Share Index	21-08-06	CI
UDG Healthcare plc(LSE:UDG) dropped from FTSE 350 Index	21-08-06	CI
UDG Healthcare plc(LSE:UDG) dropped from S&P Global BMI Index	21-08-06	CI
UDG HEALTHCARE : Barclays Downgrades UDG Healthcare To Equal-Weight, Raises PT	21-07-29	MT
UDG Healthcare : $4.1 Billion Takeover by Clayton, Dubilier & Rice to Complete in August	21-07-27	MT
UDG Healthcare Declares Voting Results to Shareholders	21-07-22	CI
UDG Healthcare Shareholders Announce Voting Date for CD&R Proposal	21-07-05	CI
M&G Rejects £2.8bn Offer for UDG Healthcare	21-06-30	CI
Stoxx Europe 600 : European Shares End Higher As UDG Healthcare Recommends Final Offer from CD&R	21-06-29	MT
FTSE : Miners, retail fuel FTSE 100 as rising COVID cases cause concern	21-06-29	RE
UDG Healthcare : Directors Recommend Final $4 Billion Clayton, Dubilier & Rice Takeover Offer	21-06-29	MT
FTSE 100 Rises 0.3% as Construction Stocks Gain	21-06-29	DJ
Miners, retail fuel FTSE 100 as rising COVID cases cause concern	21-06-29	RE
UDG Healthcare : CD&R confirms sweetened bid to take UDG Healthcare private at $3.83 billion	21-06-29	RE
UDG Healthcare Provides Information to the Shareholders	21-06-29	CI
UDG Healthcare Provides Information to the Shareholders	21-06-29	CI
CD&R Confirms Sweetened Bid to Take UDG Healthcare Private at $3.83 Billion	21-06-29	CI

Chart UDG Healthcare plc

Duration

Period

More charts

Company Profile

UDG Healthcare Ltd, formerly UDG Healthcare PLC, is an Ireland-based company that provides healthcare advisory, communications, commercial, clinical and packaging services. The Company operates across two divisions: Ashfield and Sharp. Ashfield provides advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to healthcare companies. Sharp provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries. Sharp operates its facilities in the United States and Europe.

Sector

More about the company